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Abstract
Background: Anecdotal evidence suggests that male sex
hormones are proatherogenic. We hypothesized that the male
sex hormone receptor, the androgen receptor (AR), acts as a
molecular switch in sex-specific inflammatory signaling in
vascular cells.
Materials and methods: AR expression in human umbilical
vein endothelial cells (HUVECs), human monocyte-derived
macrophages (MDMs) or HeLa cells was modulated by
transfection with AR siRNA or human AR cDNA expression
vector. Activity and expression levels were measured by
luciferase reporter assays, Western blotting or real-time PCR
analysis.
Results: AR knockdown reduced expression of vascular cell
adhesion molecule-1 (VCAM-1) in genetically male HUVECs.
Conversely, AR upregulation in genetically female HUVECs
induced VCAM-1 expression and increased dihydrotestos-
terone-stimulated monocyte adhesion. Co-transfection of an
AR expression vector with VCAM-1 or NF-kB-reporter vec-
tors into phenotypically female, AR-negative HeLa cells
confirmed AR regulation of VCAM-1 expression as well as
AR activation of NF-kB. AR upregulation was not sufficient
to increase ICAM-1 levels in female HUVECs or lipoprotein
metabolism gene expression in female MDMs, despite AR
knockdown limiting expression in their male counterparts.
Conclusions: AR acts as a molecular switch to induce
VCAM-1 expression. Low AR levels in female HUVECs
limit NF-kB/VCAM-1 induction and monocyte adhesion and
could contribute to the gender bias in cardiovascular disease.
Unidentified factors in female cells limit induction of other
proatherogenic genes not primarily regulated by NF-kB.
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Introduction
In all developed countries, men have an earlier and greater
incidence of cardiovascular disease than that found in age-
matched women (1). Studies have clearly defined a protec-
tive role for female hormones in this dichotomy (2),
however, the role of male hormones, or androgens, remains
ambiguous. Anecdotal evidence suggests that androgens are
proatherogenic (3), yet this has not been upheld in animal
studies examining effects on early lesion development (4–6).
It has been shown in vitro that androgens can modulate two
key processes in early lesion formation that could contribute
to the male predisposition to atherosclerosis. The potent non-
aromatizable androgen, dihydrotestosterone (DHT), has been
shown to increase monocyte-endothelial cell adhesion via
upregulation of vascular cell adhesion molecule-1 (VCAM-1)
(7, 8). DHT also stimulates intracellular cholesterol ester
accumulation in monocyte-derived macrophages (MDMs)
and increases the rate of cholesterol ester hydrolysis (9), cri-
tical processes leading to foam cell formation (10).
An important facet of these findings was the ability of
DHT to stimulate these effects in a sex-specific manner. Pub-
lished data from this laboratory has shown that DHT
(4–400 nmol/L) dose-dependently induces VCAM-1 expres-
sion in male, but not female, endothelial cells (ECs) (7, 11).
Similarly, DHT (4–400 nmol/L) enhances cholesteryl ester
uptake in MDMs from male, but not female, donors (8) in
conjunction with sex-specific induction of genes involved in
lysosomal degradation (lysosomal acid lipase or LAL) and
post-lysosomal processing wacyl coA: cholesterol acyltrans-
ferase 1 (ACAT1) and hormone-sensitive lipase (HSL)x (9).
Sex-specific effects in both MDMs and ECs correlates with
higher expression of the cognate receptor for androgen
action, the androgen receptor (AR), in male-derived cells
compared to female-derived cells (7, 12) and the higher AR
expression in male ECs was associated with higher basal
levels of VCAM-1 expression (7). Both DHT-induced
VCAM-1 expression in male ECs (7, 8) and cholesterol ester
accumulation in male MDMs (12) could be blocked by the
AR antagonist, hydroxyflutamide (HF), consistent with an
AR-dependent mechanism. Differential AR expression
between the sexes could therefore underlie the gender-spe-
cific effects of DHT on both monocyte adhesion and foam
cell formation.
We postulate the AR is the molecular switch in males
driving the sex-specific effects of DHT on VCAM-1 expres-
sion, monocyte adhesion and cholesterol ester accumulation,
and that low levels of cellular AR in females confers pro-
tection from these proatherogenic androgen effects. The aims
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of this study were therefore to investigate the ability of AR
overexpression in genetically female ECs and MDMs to pro-
mote these responses.
Materials and methods
Plasmids
The AR expression vector, pSVARo, was provided by Professor
Albert O. Brinkmann (Department of Endocrinology and Reproduc-
tion, Erasmus University Rotterdam, The Netherlands) (13). An AR
short interfering RNA (AR siRNA) expression plasmid was pur-
chased from Millipore (Millipore, Billerica, MA, USA). pZEOSV2q
was purchased from Invitrogen (Invitrogen Corporation, Carlsbad,
CA, USA). pNF-kB-luciferase and pRL-TK (used as a control for
transfection efficiency) were purchased from Promega (Promega
Corporation, Madison, WI, USA). VCAM-1 promoter (F2)-lucifer-
ase reporter vector was constructed as previously described (7).
Cell culture
Human umbilical vein endothelial cells (HUVECs) were isolated
from male or female infant umbilical cords by the collagenase dis-
persion method as described previously (14) and maintained in phe-
nol-red free M199 supplemented with 20% charcoal-stripped human
serum, 0.5% EC growth promoter, 100 U/mL penicillin and 100
mg/mL streptomycin. EC monolayers were propagated on gelatin-
coated flasks (8), passaged by trypsinization at 90% confluency and
used at passages 2–4. HeLa cells (ATCC, Manassas, VA, USA)
were maintained in RPMI 1640 medium supplemented with 10%
charcoal-stripped fetal bovine serum and seeded at 1=105 cells/cm2
in 12-well plates for transfection experiments. Human monocytes
were isolated from white cell concentrates (buffy coats) from the
peripheral blood of healthy human volunteers (Red Cross Blood
Bank) as described previously (15). The monocytes were used
immediately for the monocyte-adhesion assays or plated onto
12-well plates at 1=105 cells/cm2 and cultured in phenol red-free
RPMI 1640 medium supplemented with 20% charcoal-stripped
human serum for a 10-day period to allow monocyte-macrophage
differentiation. Treatments consisted of medium containing 0.1%
ethanol as control (used to dissolve DHT); (ii) DHT 400 nmol/L;
(iii) DHT 400 nmol/LqHF 4 mmol/L and HF 4 mmol/L. Cells were
treated with DHT at 400 nmol/L only, as we have previously pub-
lished that this dose elicits maximal effects on both cell adhesion
and macrophage lipid accumulation and yet reflects those seen at
the more physiological doses of 4 and 40 nmol/L (7, 8, 12).
Transient cell transfections and luciferase
measurements
One day before transfection, HeLa cells were seeded at 1=105 cells
per well in a 12-well plate. Cells were transfected with Gene-
PORTER 2 (Genlantis, San Diego, CA, USA, 5 mL), serum-free
M199 (20 mL) and plasmid mix diluted in DNA diluent (25 mL).
The plasmid mixes used were: (i) pNF-kB-luciferase 100 ngq
pZEOSV2q 100 ng (a control plasmid to make up total plasmid
DNA to 200 ng)qpRL-TK 40 ng; (ii) pNF-kB-luciferase 100 ngq
pSVARo 100 ngqpRL-TK 40 ng; (iii) pVCAM-1(F2)-luciferase
100 ngqpZEOSV2q 100 ngqpRL-TK 40 ng; (iv) pVCAM-1(F2)-
luciferase 100 ngqpSVARo 100 ngqpRL-TK 40 ng. The plasmid-
GenePORTER 2 suspensions were incubated with cells for 4–6 h,
were then washed with phosphate buffered saline (PBS) before
1 mL fresh medium was added and cells were incubated for a further
48 h. Cells were lysed with passive lysis buffer (250 mL/well; Pro-
mega) and analyzed for luciferase and renilla activity using the
Dual-Luciferase Reporter System (Promega).
HUVECs were seeded (1=105 cells/well) in a 12-well plate. To
silence AR expression in HUVECs from male donors, a mixture of
8 mg of AR siRNA plasmid, serum-free M199 (20 mL) and
GenePORTER2 (5 mL) was prepared and transfection performed
(Genlantis). After 16 h incubation, cells were washed twice with
PBS, 1 mL fresh medium was added and the cells were incubated
for a further 24 h. Total RNA was then harvested from the cells for
real-time PCR analysis. To increase AR expression in HUVECs
from female donors, 3=106 cells in log phase were suspended in a
0.4-cm electroporation chamber containing 800 mL cold opti-MEM
(Invitrogen), AR expression plasmid (2.5 mg pSVARo) and DEAE-
Dextran (4 mg) and transfected by electroporation (exponential
decay of 250 V and 960 mFarads). After electroporation, cells were
seeded (1=105 cells/well) in a 12-well plate and incubated for 24 h.
The following day, cells were washed twice with PBS and refreshed
with treatment medium containing 0.1% ethanol, DHT 400 nmol/L,
DHT 400 nmol/LqHF 4 mmol/L or HF 4 mmol/L. Total RNA was
harvested from cells after 48 h of treatment and analyzed by real-
time PCR.
Overexpression of AR in genetically female human monocyte-
derived macrophages (HMDMs) was performed by transfection of
the HMDMs on days 7–8 with pSVARo (0.3 mg) and 5 mg/mL
DEAE-Dextran for 30 min at 378C. Medium (1.5 mL) was then
added to the cells and cells were incubated for a further 1.5 h after
which time the growth medium was changed and the cells were
incubated for a further 24 h. The transfected cells were subsequently
treated with either vehicle control (0.1% ethanol) or DHT
(400 nmol/L) for 24 h before harvesting total RNA for real-time
PCR analysis.
Real-time PCR
Total RNA was extracted from cells using TRI reagent (Sigma-
Aldrich, Castle Hill, NSW, Australia) and the concentration nor-
malized to 100 ng/mL using the SYBR Green II assay (Molecular
Probes, Invitrogen, Melbourne, Australia). Specific cDNA was
reverse transcribed from 100 ng of total RNA using iSCRIPT (Bio-
Rad, Regents Park, NSW, Australia), according to the manufactur-
er’s protocol. An aliquot of each cDNA sample (1.2 mL) was
amplified by real-time PCR in reaction mixtures containing primers
(12 pmol each) and iQ SYBR Green Supermix. Amplification was
performed in an iCycler iQ thermocycler (Bio-Rad) with thermal
cycle conditions: 958C for 3 min, followed by 35 cycles at the
annealing temperature of specific primer sets (Tm) for 30s and 728C
for 30s (Table 1). Relative changes in mRNA gene expression
between treatments were determined by the ‘‘Delta-delta’’ compar-
ative (DDCT) method (16) and normalized using the reference genes,
18S and b2-microglobulin. Primer sequences are listed in Table 1.
Western blot analysis
Whole protein lysate was extracted from HUVECs. Briefly, cells
were harvested with trypsin and washed with cold PBS after cen-
trifugation. Cells were lysed by the addition of RNA lysis buffer
and then incubated on ice for 20 min. Cell lysate was cleared by
centrifugation and the supernatant collected for protein estimation.
SDS-PAGE in 8% polyacrylamide resolving gels was used to sep-
arate total protein according to size (Bio-Rad electrophoresis unit).
Resolved protein samples were transferred to PVDF membranes in
transfer buffer at 30 V overnight in the cold room or 70 V for 3 h
at room temperature. Membranes were then blocked with 5% skim
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Table 1 Primer sequences for real-time PCR.
Gene Sequence Tm, 8C
VCAM1-F ATG TAG TGT CAT GGG CTG TG 60
VCAM1-R GGA ATG AGT AGA GCT CCA CC
ICAM1-F CCA TCT ACA GCT TTC CGG CGC 60
ICAM1-R CTC TGG GGT GGC CTT CAG CA
AR-F CAA AAG AGC CGC TGA AGG GAA ACA 55
AR-R TTC TTC AGC TTC CGG GCT CCC AGA
ACAT1-F AGT TGA CAG CAG AGG CAG AG 55
ACAT1-R GGA TAA AGA GAA TGA GGA GGG
LAL-F GCA ACA GCA GAG GAA ATA C 59
LAL-R GAG AAT GAC CCA CAT AAT ACA C
Caveolin-2-F TGC AGA CAA TAT GGA AGA G 59
Caveolin-2-R GAA ATG AAC AGA ACA GTG G
HSL-F CCG ACT TCC TCC GGG AGT AT 59
HSL-R GTC TCG TTG CGT TTG TAG TGC T
18S-F CGG CTA CCA CAT CCA AGG AA 60
18S-R GCT GGA ATT ACC GCG GCT
B2M-F GGC TCG CTT CGT GGC CTT GG 60
B2M-R TTT CAA TCT GGG GTG GAT GGA ACC C 59
Primer sequences that were used for real-time PCR obtained using Beacon Designer software. VCAM-1, vascular cell adhesion molecule-
1; ICAM-1, intercellular cell adhesion molecule-1; AR, androgen receptor; ACAT-1, acyl coA: cholesterol acyltransferase 1;
LAL, lysosomal acid lipase; HSL, hormone sensitive lipase; 18S, 18 ribosomal S RNA; B2M, b2-microglobulin.
Figure 1 Male-derived endothelial cells express more AR than
female-derived endothelial cells.
Total protein was isolated from male- or female-derived HUVECs
or prostate cancer cells (LnCAP, positive control) and Western blot
analysis used to probe for AR expression.
milk powder in Tris buffered saline Tween-20 (TBST) for 1 h,
washed with TBST (3=) before overnight incubation with human
monoclonal AR antibody (1:500 dilution, AR441/sc7305, Santa
Cruz Biotechnology, Santa Cruz, CA, USA). Membranes were then
washed in TBST (3=) and incubated with secondary antibody con-
jugated to horseradish peroxidase for 2 h at room temperature. The
membrane was then washed three times with TBST, and immuno-
detection was accomplished with enhanced chemiluminescence
(Amersham Biosciences, Castle Hill, NSW, Australia). Membranes
were directly digitized and band densities measured using Quantity
One Software (Bio-Rad).
Cell adhesion assay
HUVECs from female donors (transfected with the AR expression
plasmid as described above) were seeded in gelatin-coated 12-well
plates at 1=105 cells/mL for 24 h before exposure to the following
treatments: (1) 0.1% ethanol and (2) DHT 400 nmol/L. After the
treatment period, monocyte-endothelial cell adhesion assays were
performed as described previously (8).
Statistical analysis
Results are reported as mean"SEM. Statistical significance be-
tween groups was assessed using the unpaired two-sided Student’s
t-test. Multiple comparisons were performed using one-way analy-
sis of variance (ANOVA) and Bonferroni’s post-hoc analysis
where appropriate. A p-value -0.05 was considered statistically
significant.
Results
AR upregulation in female cells increases VCAM-1
but not ICAM-1 expression
Genetically female ECs express relatively little AR protein
compared to male ECs (Figure 1). To determine whether the
absence of DHT-mediated induction of VCAM-1 expression
observed previously in female-derived ECs (7) is a conse-
quence of low AR expression, female-derived HUVECs
were transfected with an AR expression vector (pAR). AR
expression noticeably increased in transfected versus non-
transfected cells. Elevated AR levels led to a 2.3-fold
increase in VCAM-1 expression (p-0.05 compared to non-
transfected controls) but had no significant effect on ICAM-
1 expression (Figure 2A). We next determined, whether the
AR-induced increase in VCAM-1 expression in female-
derived cells was associated with an increase in mono-
cyte binding. One of the earliest pathogenic events in the
development of atherosclerosis is the binding of monocytes
to the endothelium, orchestrated by increased expression of
VCAM-1 on the cell surface of endothelial cells. Monocyte-
endothelial cell adhesion assays were performed on female
HUVECs transiently transfected with the AR expression
vector (pSVARo) then exposed to vehicle or DHT (400
nmol/L). In female HUVECs, overexpression of AR alone
did not significantly increase monoctye adhesion, however,
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Figure 2 Increased AR expression levels induce VCAM-1 and
ICAM-1 expression.
(A) Total RNA was extracted from female-derived HUVECs trans-
fected with an AR expression vector (pAR) and RT-PCR was used
to measure AR, VCAM-1 and ICAM-1 expression. Inset, AR pro-
tein levels in non-transfected (lane 1) and pAR-transfected (lane 2)
female-derived HUVECs. Results are expressed as mean"SEM of
relative expression value (%) obtained from triplicate values from
two female donors. *p-0.05, **p-0.005 vs. sex-specific non-
transfected control (one-way ANOVA with Bonferroni’s post-hoc
analysis). (B) AR overexpression enhances DHT-induced monocyte-
endothelial cell adhesion to female-derived cells. HUVECs isolated
from female donors were transfected with an AR expression vector
(pAR) and exposed to 0.1% ethanol (vehicle control) or DHT
400 nmol/L (DHT) for 48 h. *p-0.05 vs. female non-transfected
control (one-way ANOVA with Bonferroni’s post-hoc analysis).
Figure 3 Silenced AR expression levels decrease VCAM-1
expression.
Total RNA was extracted from male-derived HUVECs transfected
with an AR siRNA plasmid (siAR). AR, VCAM-1 and ICAM-1
mRNA levels were measured by real-time PCR. Results are
expressed as mean"SEM of relative expression value (%) obtained
from triplicate values from a single male donor. *p-0.05,
**p-0.005 vs. sex-specific non-transfected control (one-way
ANOVA with Bonferroni’s post-hoc analysis).
in the presence of DHT-liganded AR, monocyte adhesion
increased dramatically (20%, p-0.05 vs. non-treated trans-
fected controls) (Figure 2B). DHT failed to increase mono-
cyte adhesion in non-transfected female HUVECs, therefore
highlighting that AR-induced VCAM-1 expression leads to
a physiologically significant atherogenic endpoint.
AR silencing in male ECs reduces both VCAM-1 and
ICAM-1 expression
To test that the converse is also true, that lowering AR
expression decreases VCAM-1 expression, male-derived
HUVECs were transfected with siRNA targeting AR mRNA.
It was demonstrated that a 2.4-fold reduction in AR mRNA
levels (p-0.005 compared to non-transfected controls) led
to a 7.7-fold reduction in VCAM-1 expression (p-0.005
compared to non-transfected controls) and a 1.5-fold reduc-
tion in ICAM-1 expression (p-0.05 compared to non-trans-
fected controls) (Figure 3), unequivocally demonstrating a
role for the AR in VCAM-1 and ICAM-1 expression in male-
derived ECs.
AR upregulation in phenotypically female cells
increases NF-kB activity
To investigate the findings in female cells further, HeLa
cells which are phenotypically female and do not express
AR were transiently transfected with an AR expression vec-
tor (pSVARo) and a VCAM-1 promoter luciferase reporter
construct. AR expression in HeLa cells increased VCAM-1
promoter activity 1.7-fold (p-0.05 compared to non-
pSVARo transfected controls) (Figure 4) showing that
increased AR was activating VCAM-1 gene transcription.
As we previously identified that DHT-stimulated AR acti-
vates NF-kB and that it is activated NF-kB that drives the
DHT-induced VCAM-1 expression in male cells (7), we next
investigated whether increased AR in phenotypically female
cells also led to NF-kB activation. HeLa cells were trans-
fected with the AR expression vector (pSVARo) and an NF-
kB-luciferase reporter vector. AR expression increased
NF-kB-luciferase activity 1.8-fold (p-0.05 vs. non-pSVARo
transfected controls) (Figure 4) confirming that AR when
present in high enough amounts can modulate NF-kB activ-
ity in female ECs.
AR upregulation in female MDMs does not induce
lipoprotein metabolism genes
The accumulation of cholesteryl esters in macrophages leads
to foam cell formation, a second important event in early
atherosclerotic plaque formation. We have previously shown
that DHT increases lipid accumulation in human monocyte-
derived macrophages (MDMs) in a sex-specific manner, with
the effect measured in male but not female cells and asso-
ciated with DHT-induced expression of the lipoprotein
metabolism genes ACAT1, LAL, HSL and caveolin-2 (CAV-
2) (9). Given the AR dependence of VCAM-1 in human
endothelial cells, we tested whether the expression of the
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Figure 4 AR expression in HeLa (AR–) cells increases NF-kB
activation and VCAM-1 promoter activity.
HeLa cells were transfected with (i) pVCAM-1-luciferase reporter
vector (F2, control), (ii) pVCAM-1-luciferase reporter vector and
pAR expression vector (pVCAM-1qpAR), (iii) pNF-kB-luciferase
reporter vector (pNF-kB) or (iv) pNF-kB-luciferase reporter vector
and pAR expression vector (pNF-kBqpAR). Results are reported
as mean percentage"SEM of cells transfected with pNF-kB or
pVCAM-1 and represent 3–5 separate experiments. *p-0.05 com-
paring pNF-kB vs. pNF-kBqpAR or pVCAM-1 vs. pVCAM-1q
pAR (Student’s t-test).
Figure 5 AR protein expression in HMDMs from female donors
transfected with an AR expression vector.
HMDMs were transfected with pAR to increase AR levels. Then,
24 h after transfection, cells were treated with DHT (pAR-DHT;
400 nmol/L) or vehicle control (pAR-C; 0.1% ethanol) for 24 h.
Total protein was extracted and Western blot analysis was used to
measure AR levels relative to b-actin levels. Membranes were
directly digitized and Quantity One was used to measure band den-
sities. All AR levels were normalized to b-actin levels. Data are
presented as mean"SEM. *p-0.05 vs. corresponding control (one-
way ANOVA with Bonferroni’s post-hoc analysis).
lipid metabolism genes were similarly modulated by increas-
ing AR levels in MDMs. Female MDMs were transfected
with pAR and were treated or not treated with DHT
(400 nmol/L, Figure 5). In female MDMs overexpressing AR
there was no significant increase in ACAT, LAL or CAV-2
mRNA levels (Figure 6A–D). To test if AR required acti-
vation to increase gene transcription, transfected female cells
were treated with DHT, however, no further induction was
observed. HSL mRNA increased modestly upon DHT treat-
ment but was not statistically significant (Figure 6D). In con-
trast, DHT treatment of non-transfected, male MDMs
significantly induced transcription of all four genes (Figure
6), consistent with earlier studies (9).
Discussion
This study demonstrates that AR, activated or unactivated,
can act as a molecular switch in human vascular endothelial
cells to activate NF-kB thereby driving sex-specific NF-kB-
dependent VCAM-1 expression and monocyte adhesion, key
early steps in atherosclerosis establishment. Conversely, this
study has revealed that AR alone, unactivated or activated,
is not sufficient for regulating the sex-specific expression of
ICAM-1 in ECs or genes involved in lipid metabolism in
female-derived MDMs. Increasing AR levels in MDMs from
female donors did not significantly increase ACAT, LAL,
HSL or CAV-2 expression, even after DHT activation, sug-
gesting the AR could be interacting with other cofactors or
nuclear factors in male cells to increase lipid metabolism
genes and subsequent lipid accumulation, factors that could
be missing or poorly expressed in female versus male cells.
The most striking finding of this study is that AR is acting
as a molecular switch enabling or disabling proinflammatory
effects in human ECs via its activation of NF-kB. It has
previously been shown by our laboratory that DHT dose-
dependently mediates upregulation of VCAM-1 and mono-
cyte-endothelial cell adhesion in male cells through the AR,
as the effect of DHT could be significantly abrogated by
pharmacological blockade with an AR antagonist (8).
Accordingly, this effect was postulated to be sex-specific
owing to the higher levels of AR in male compared to female
ECs (7). We have now shown conclusively that in male ECs
VCAM-1 expression is dependent upon AR and demonstrate
that by simply increasing AR in female endothelial cells,
their behavior changes to mimic male cells. Male-specific
expression of AR activates NF-kB and subsequently VCAM-
1 expression in male endothelial cells, leading to increased
monocyte adhesion (7). Female cells that inherently express
less AR are therefore protected from this early atherosclerotic
inflammatory event. These results exclusively demonstrate
the pivotal role AR plays in this androgen-induced proin-
flammatory, proatherogenic process. The role of AR in such
proinflammatory activities and the gender-specific expression
of AR could be responsible, at least in part, for the male
predisposition to early onset atherosclerosis.
The finding that AR was central to the sex-specific expres-
sion of VCAM-1, but not ICAM-1, is most likely related to
the key dependence of VCAM-1 expression on NF-kB (7,
11). Previous promoter-deletion studies have demonstrated
the significance of the NF-kB binding site in androgen-
induced VCAM-1 expression (7) and that 4–400 nmol/L
DHT-stimulated AR activates NF-kB and that it is active
NF-kB that drives DHT-induced VCAM-1 expression in
male ECs. The failure of AR to induce ICAM-1 expression
in female-derived cells appears not to be due to a lack of
induction of NF-kB, as we demonstrated that AR can also
drive NF-kB activity in phenotypically female cells. Instead,
such findings could be a consequence of sex-specific expres-
sion of other nuclear factors, as ICAM-1 is regulated by
multiple transcription factors acting in concert (17), or a con-
sequence of sex differences in the expression of specific
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Figure 6 Sex-specific expression of lipoprotein metabolism genes in human monocyte-derived macrophages (MDMs). Non-transfected
MDMs from male and female donors, and female-derived MDMs transfected with an AR expression vector (pAR) were treated with vehicle
(0.1% ethanol, control) or DHT (400 nmol/L) for 24 h. Total RNA was extracted and mRNA expression levels of ACAT1 (A), LAL (B),
CAV-2 (C) and HSL (D) were determined by real-time PCR. Results were normalized to the housekeeping gene, 18S, and expressed as
mean"SEM (ns3) relative to vehicle controls (100%). *p-0.05 vs. corresponding control (one-way ANOVA with Bonferroni’s post-hoc
analysis).
nuclear cofactors. There is evidence for promoter-specific
regulation of several NF-kB-dependent genes, including
ICAM-1 and VCAM-1, coordinated by an array of NF-kB
cofactors. For example, poly (ADP-ribose) polymerase-1
(PARP-1) is essential for NF-kB dependent ICAM-1, but not
VCAM-1, expression in murine smooth muscle cells (18).
Similarly, coactivator-associated arginine methyltransferase-
1 (CARM-1) exhibits promoter-specific regulation of several
NF-kB dependent genes, including ICAM-1, in CARM-1
knockout cells (19). There is no evidence to date for sex-
specific expression of PARP-1 or CARM-1, however, we
have observed lower expression of another cofactor, p300,
in immunostained sections of mesenteric arteries from
female compared to male subjects (unpublished observa-
tions). p300 directly associates with PARP-1 and both p50
and p65 (RelA) subunits of NF-kB to synergistically activate
transcription (20). Acetylation of PARP-1 by p300/CBP is
also necessary for coactivation of NF-kB transcription (21).
Further investigation is warranted into possible gender dif-
ferences in the expression of these or a growing number of
cofactors that interact with the AR and/or NF-kB (19, 22)
and any subsequent contribution to sex-specific inflamma-
tory signaling.
Limiting levels of other nuclear factors could also explain
the lack of induction of lipoprotein metabolism genes in
female MDMs in the presence of increased levels of AR and
DHT. This and previous studies show that these same genes
are readily inducible by pharmacological and physiological
concentrations of DHT in male cells, and inhibition by AR-
specific antagonists demonstrates AR dependence (9). AR is
therefore important for male regulation of the lipid metabo-
lism genes, however, as female cells with increased AR
remain unresponsive to DHT in this regard, it suggests that
AR must be acting with other cofactors/nuclear factors and
itself is not sufficient to drive expression of lipid metabolism
genes. Like ICAM-1, transcriptional control of the lipid
metabolism genes is highly complex and involves concerted
combinations of transcription factors. There is evidence for
an NF-kB role in LAL and HSL transcriptional control but
no obvious involvement in CAV-2 or ACAT1 expression (23,
24). The androgen-sensitivity of HSL and CAV-2 in male
MDMs could instead be a consequence of their regulation
by the sterol regulatory element binding protein (SREBP)
(23), whose activity is AR-dependent via upstream regulation
of escort proteins, SCAP (SREBP cleavage activating pro-
tein) and insig-1 and -2 (25).
In summary, the data presented here show that AR acts as
a molecular switch that promotes early proatherogenic pro-
cesses in male ECs via NF-kB activation. Increasing AR
expression in female ECs increased VCAM-1 expression and
monocyte-endothelial cell adhesion, unequivocally demon-
strating the AR-dependence of these key early steps in early
lesion development. Low expression of AR in female ECs
limits VCAM-1 activation in response to androgens and
could contribute to the gender bias in cardiovascular disease.
Inability of AR overexpression in phenotypically female
cells to induce other atherogenic genes suggests sex-specific
expression of other transcription factors or cofactors that act
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with AR or NF-kB could also play a role in limiting vascular
inflammation and early lesion development in women and
deserve further study.
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